🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Cabotegravir Tablets

Found 52 matching trials

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

PHASE2

The goal of this clinical study is to learn more about the effects of switc...

Status

Active Not Recruiting

Location

Be Well Medical Center

Start Date

2022-08-16

Trial ID

NCT05502341

Treatments Being Tested

Bictegravir Lenacapavir BIC/LEN FDC Stable Baseline Regimen

A Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects

PHASE1

This study will evaluate two new GSK1265744 sodium salt tablet formulations...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-02

Trial ID

NCT02059031

Treatments Being Tested

GSK1265744 Reference formulation GSK1265744 New formulation 1 GSK1265744 New formulation 2

A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers

PHASE1

This will be a Phase 1, open-label, parallel group, two-part, single-dose a...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-06-22

Trial ID

NCT02354950

Treatments Being Tested

GSK1265744 30mg

Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)

PHASE2

This study is a Phase IIa, randomized, multi-site, two-arm, double-blinded ...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-03-27

Trial ID

NCT02076178

Treatments Being Tested

744 Tablet 744 LA Injection Placebo Tablet Placebo Injection

An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

PHASE1

This will be a two-part study in healthy adults. Part A is a phase 1, non-r...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-05

Trial ID

NCT01848340

Treatments Being Tested

GSK1265744B (sodium salt) containing 14C-GSK1265744B 150 mg GSK1265744B Placebo

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

PHASE3

The purpose of this study is to evaluate if offering long-acting injectable...

Status

Not Yet Recruiting

Location

Hôpital Hôtel Dieu

Start Date

2024-04-01

Trial ID

NCT06273943

Treatments Being Tested

Cabotegravir Tablets, for oral use.Cabotegravir Extended-Release Injectable Suspension, for intramuscular use.Tenofovir disoproxil/Emtricitabine 300mg/200mg fixed-dose combination tablets, for oral use Rectal Biopsies

Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males

PHASE2

This study will establish the minimum safety, tolerability and acceptabilit...

Status

Completed

Location

University of Colorado Denver ATN CRS

Start Date

2020-02-19

Trial ID

NCT04692077

Treatments Being Tested

Cabotegravir (CAB) tablet CAB LA Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) tablet

Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults

PHASE3

This Antiretroviral Therapy as Long Acting Suppression every 2 Months (ATLA...

Status

Active Not Recruiting

Location

GSK Investigational Site

Start Date

2017-10-27

Trial ID

NCT03299049

Treatments Being Tested

Cabotegravir Tablets Rilpivirine Tablets Cabotegravir Injectable Suspension Rilpivirine Injectable Suspension

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

PHASE2

This study is a Phase IIb, randomized, multicentre, parallel group, open-la...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-04-28

Trial ID

NCT02120352

Treatments Being Tested

CAB Oral Tablets CAB LA ABC/3TC Oral tablets RPV Oral Tablets HAART RPV

A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects

PHASE1

This is a single-center, randomized, open-label, 3 parallel treatment study...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-01

Trial ID

NCT01754116

Treatments Being Tested

GSK1265744 30 mg oral Midazolam 3 mg oral + GSK1265744 30mg oral GSK1265744 400 mg (200 nm)GSK1265744 400 mg (1 micro m)GSK1265744 400 mg (5 micro m)

Previous Next